Just for a bit of balance, Jon did stress that success in the other 3 trials would not be measured against the outstanding PMS result, but rather against the less impressive Rett's P2 result, which also led to approval.
IMO, bit of a 'rosy' to assume his comments suggested that AS & PHS were matching PMS. Instead of implying anything about how the trials were progressing, he was just stating what would be regarded as success. Which is totally fair enough.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |